Pay in 4 interest-free payments of $5.97 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Long-Acting Amylin Agonist GUB014295 Gubra A/S (Hrsholm, Denmark), a biotech company specialized in pre-clinical contract research, initiated a phase 1 clinical trial (NCT06144684) to investigate the safety, tolerability and pharmacological properties of GUB014295 (GUBamy), a long-acting OW SC amylin agonist, in healthy volunteers [117]
Villalpando-Rodriguez GE, Gibson SB
Plan sponsors may need to navigate PBM contracts, ACA compliance, HRA rules, and HDHP coordination concerns before implementing one of these programs
Instead, follow local guidelines for medication disposal
US$ 24.31
US$ 28.41
US$ 20.00
US$ 26.55
US$ 20.26
US$ 21.31
US$ 20.94
![Mana Vault [Ultimate Masters] SM149](https://cdn.shopify.com/s/files/1/0580/9766/4113/files/4887d331-b7e0-5c8f-9075-3dddae6c9198.jpg?v=1732545651)
